资讯

Yahoo Finance4 年

PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical ...

HERZLIYA, ISRAEL / ACCESSWIRE / January 4, 2021 / PainReform Ltd. (NasdaqCM:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of ...
Finanznachrichten4 年

PainReform Ltd.: PainReform Announces Appointment of Lotus Clinical Research as CRO for ...

HERZLIYA, ISRAEL / ACCESSWIRE / January 4, 2021 / PainReform Ltd. (NasdaqCM:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of ...